Materials • Major Chemicals
$5.54 ▲ +0.07
(+1.28%)
MKT CAP: $313.1M • VOL: 403.9K
52W L $4 52W H $9
ROARABLE / RQD
D+ • 52/100
PIOTROSKI
4 / 9
OEC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.81B | $1.88B | $1.89B |
| YoY Revenue Growth % | -3.8% | -0.9% | — |
| Gross Profit | $359.8M | $428.8M | — |
| Gross Margin % | 19.9% | 22.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $27.5M | $102.7M | $205.3M |
| Operating Margin % | 1.5% | 5.5% | 10.8% |
| Net Income (GAAP) | -$70.0M | $44.0M | $104.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $215.8M | $125.3M | $345.9M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $215.8M | $125.3M | $345.9M |
| FCF Margin % | 11.9% | 6.7% | 18.3% |
| Return on Invested Capital (ROIC %) | 2.2% | 7.5% | — |
| Cash & Short-Term Equivalents | $60.7M | $44.2M | — |
| Total Debt (Short + Long Term) | $674.5M | $647.0M | — |
| Total Stockholders' Equity | $384.6M | $474.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR OEC.